PureTech Health plc
A clinical-stage biotherapeutics company developing new medicines for devastating diseases.
PRTC | IL
Overview
Corporate Details
- ISIN(s):
- GB00BPVG5C82 (+2 more)
- LEI:
- 213800LVPDNO2Z9T9I39
- Country:
- United States of America
- Address:
- 6 TIDE STREET, 2210 BOSTON
- Website:
- https://puretechhealth.com/
- Sector:
- Manufacturing
Description
PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2018-02-20 08:00 |
Trading Statement
|
English | 43.7 KB | ||
| 2018-01-31 08:00 |
PRTC resTORbio closes IPO, adds $13M to $85M raise
|
English | 26.1 KB | ||
| 2018-01-26 08:00 |
PureTech's resTORbio successfully lists on NASDAQ
|
English | 26.5 KB | ||
| 2018-01-03 08:00 |
PRTC's resTORbio Adds Senior Biogen Exec to Board
|
English | 29.8 KB | ||
| 2018-01-02 08:00 |
PRTC's resTORbio Files Public S1 for NASDAQ IPO
|
English | 17.8 KB | ||
| 2017-12-31 01:00 |
Annual Report
|
English | 4.0 MB | ||
| 2017-12-19 08:00 |
Lilly to invest $5M in PureTech's Entrega
|
English | 34.7 KB | ||
| 2017-12-13 08:00 |
PureTech's Vedanta Granted Four New US Patents
|
English | 28.0 KB | ||
| 2017-12-11 08:00 |
PureTech's resTORbio Adds Paul Fonteyne to Board
|
English | 27.3 KB | ||
| 2017-12-07 08:00 |
PRTC: Vedanta Enters Clinic/FDA Orphan Designation
|
English | 35.3 KB | ||
| 2017-12-05 16:14 |
Increase of Holdings in Company
|
English | 66.2 KB | ||
| 2017-12-05 08:00 |
PRTC's resTORbio Files IPO Registration Statement
|
English | 19.5 KB | ||
| 2017-12-04 08:00 |
PureTech's Akili Pivotal ADHD Trial Successful
|
English | 36.5 KB | ||
| 2017-11-30 08:00 |
PureTech's resTORbio Raises $40 Million
|
English | 33.9 KB | ||
| 2017-11-29 08:00 |
PRTC's Vedanta Grows ImmunoOncology Collaborations
|
English | 37.5 KB |
Automate Your Workflow. Get a real-time feed of all PureTech Health plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PureTech Health plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PureTech Health plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
